<DOC>
	<DOCNO>NCT00134173</DOCNO>
	<brief_summary>The Torcetrapib project terminate December 2 , 2006 due safety finding . To look ultrasound image take blood vessel heart look various lipid blood people know coronary heart disease</brief_summary>
	<brief_title>A Coronary IVUS Study Compare Torcetrapib/Atorvastatin Atorvastatin Alone Subjects With Coronary Heart Disease</brief_title>
	<detailed_description>For additional information please call : 1-800-718-1021</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Torcetrapib</mesh_term>
	<criteria>angiographic evidence coronary atherosclerosis Women pregnant lactating , plan become pregnant . Subjects clinically indicate need statin ( HMGCoA reductase inhibitor ) therapy atorvastatin concomitant therapy know lipid alter effect LDLC HDLC include fibrates nicotinic acid . Subjects take drug know associate increase risk myositis combination HMGCoA reductase inhibitor . Subjects medical condition laboratory abnormality could affect subject safety , preclude evaluation response , render unlikely subject would complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>